Skip to main content
Contact Us
Subscribe
E-Edition
58°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Can AbbVie Beat Pfizer in the Atopic Dermatitis Market?
January 29, 2022
Tickers
ABBV
PFE
REGN
SNY
Tags
SNY
Market News
PFE
From
Motley Fool
Regeneron, Sanofi Withdraw FDA Application For Libtayo's Expanded Use
January 28, 2022
Tickers
REGN
SNY
Tags
Health Care
Cervical Cancer
REGN
From
Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
January 28, 2022
Tickers
ALXO
BGNE
BIIB
IBB
Tags
IBB
NRIX
BGNE
From
Benzinga
J&J exec says biotechs aren’t ‘necessarily on sale’ even after a challenging 2021
January 27, 2022
Tickers
BNTX
DRG
IBB
JNJ
Tags
JNJ
IBB
XBI
From
MarketWatch
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
Tickers
BNTX
GSK
LLY
MRK
Tags
REGN
BNTX
GSK
From
MarketWatch
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting
January 25, 2022
Tickers
AXP
BRO
IBM
JNJ
Tags
Eurozone
MSFT
JNJ
From
Benzinga
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
General
Antibodies
Pandemic
From
Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
January 24, 2022
Tickers
AZN
LLY
MRK
PFE
Tags
Top Stories
Covid/19
General
From
Benzinga
Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease
January 19, 2022
Tickers
REGN
SNY
Tags
Benzinga
Market News
REGN
From
Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
Tickers
ADMA
ASLN
BGNE
CRDF
Tags
BGNE
ASLN
LPTX
From
Benzinga
Regeneron Announces FDA Accepts For Review Libtayo In Combination With Chemotherapy For First-Line Treatment Of Advanced NSCLC
January 19, 2022
Tickers
REGN
Tags
REGN
FDA
Benzinga
From
Benzinga
2 Top Biotech Stocks to Buy and Hold for 10 Years
January 17, 2022
Tickers
MRK
MRNA
PFE
REGN
Tags
Market News
MRK
PFE
From
Motley Fool
3 Top Biotech Stocks to Buy Right Now
January 15, 2022
Tickers
GSK
NVS
REGN
SNY
Tags
NVS
Market News
GSK
From
Motley Fool
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
January 14, 2022
Tickers
GSK
LLY
REGN
VIR
Tags
VIR
Government
General
From
Benzinga
Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares
January 13, 2022
Tickers
CNTB
IMAB
LLY
PFE
Tags
General
REGN
Biotech
From
Benzinga
1 Key Ratio All Investors Should Be Looking at When Buying Growth Stocks in 2022
January 13, 2022
Tickers
ARKK
FUBO
REGN
TSLA
Tags
FUBO
REGN
Recent Press Releases
From
Motley Fool
Why JPMorgan Is Among Rob Sechan's Top Picks For 2022
January 10, 2022
Tickers
EOG
JPM
REGN
Tags
Market News
Long Ideas
EOG
From
Benzinga
Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
January 05, 2022
Tickers
PFE
REGN
Tags
Analyst Ratings
Market News
PFE
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
Tickers
ACAD
ADBE
ADTH
AEL
Tags
FTS
LDI
MGY
From
Benzinga
3 Healthcare Stocks That Could Rocket Higher in 2022
January 04, 2022
Tickers
ALGN
NTLA
REGN
SAVA
Tags
Recent Press Releases
REGN
NTLA
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
Tickers
ACC
ADTH
ALNY
AVB
Tags
CARR
NAVI
WOLF
From
Benzinga
Better Buy: CRISPR vs. Intellia
January 03, 2022
Tickers
BLUE
CRSP
NTLA
REGN
Tags
REGN
CRSP
Recent Press Releases
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
Tickers
ALNY
ETON
IBB
NVS
Tags
XERS
Benzinga
FDA
From
Benzinga
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
Tickers
CYDY
GILD
GSK
LLY
Tags
Opinion
CYDY
VIR
From
Benzinga
AstraZeneca's COVID-19 Antibody Effective Against Omicron Variant
December 16, 2021
Tickers
AZN
AZNCF
REGN
Tags
Biotech
AZN
News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
Tickers
ADGI
ALB
AMCR
APEN
Tags
REGN
QNRX
ROIV
From
Benzinga
2 No-Brainer Healthcare Stocks to Buy Right Now
December 13, 2021
Tickers
AMWL
BNTX
PFE
REGN
Tags
Recent Press Releases
REGN
TDOC
From
Motley Fool
Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients
December 09, 2021
Tickers
NVS
REGN
Tags
NVS
News
Briefs
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Tickers
ABBV
ALL
ALSN
AMGN
Tags
ZBH
WRB
Downgrades
From
Benzinga
Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma
December 07, 2021
Tickers
GSK
LLY
REGN
VIR
Tags
LLY
REGN
VIR
From
MarketWatch
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.